Project Details
| Short title | CIBI363A101 |
|---|---|
| Acronym | CIBI363A101 |
| Status | Active |
| Effective start/end date | 12/04/24 → 28/02/29 |
CTU: A Phase 1, Open-label, Multicenter Study of IBI363 (PD1-IL2m) in Subjects with Advanced Solid Malignancies or Lymphomas
- Park, John (Primary Chief Investigator)
- Chester, Catherine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
Project: Research